Weik Capital Management Acquires 302 Shares of VANGUARD SCOTTS/VANGUARD SHORT-TERM (VCSH)

Share on StockTwits

Weik Capital Management grew its holdings in VANGUARD SCOTTS/VANGUARD SHORT-TERM (BMV:VCSH) by 0.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 32,827 shares of the company’s stock after purchasing an additional 302 shares during the quarter. VANGUARD SCOTTS/VANGUARD SHORT-TERM makes up approximately 1.3% of Weik Capital Management’s holdings, making the stock its 24th biggest holding. Weik Capital Management’s holdings in VANGUARD SCOTTS/VANGUARD SHORT-TERM were worth $2,618,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Ellis Investment Partners LLC boosted its stake in VANGUARD SCOTTS/VANGUARD SHORT-TERM by 7,500.1% during the 1st quarter. Ellis Investment Partners LLC now owns 1,381,318 shares of the company’s stock worth $1,381,000 after acquiring an additional 1,363,143 shares during the last quarter. Jane Street Group LLC boosted its stake in VANGUARD SCOTTS/VANGUARD SHORT-TERM by 300.0% during the 4th quarter. Jane Street Group LLC now owns 1,049,604 shares of the company’s stock worth $81,807,000 after acquiring an additional 787,198 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. boosted its stake in VANGUARD SCOTTS/VANGUARD SHORT-TERM by 18.4% during the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 3,899,823 shares of the company’s stock worth $311,050,000 after acquiring an additional 607,130 shares during the last quarter. Mercer Global Advisors Inc. ADV bought a new position in VANGUARD SCOTTS/VANGUARD SHORT-TERM during the 1st quarter worth approximately $43,552,000. Finally, D. Scott Neal Inc. bought a new position in VANGUARD SCOTTS/VANGUARD SHORT-TERM during the 4th quarter worth approximately $38,504,000.

VANGUARD SCOTTS/VANGUARD SHORT-TERM stock traded down $0.01 during midday trading on Monday, hitting $79.75. 294 shares of the stock were exchanged, compared to its average volume of 11,454. VANGUARD SCOTTS/VANGUARD SHORT-TERM has a 52 week low of $1,401.70 and a 52 week high of $1,575.15.

The company also recently disclosed a monthly dividend, which was paid on Monday, May 6th. Investors of record on Thursday, May 2nd were paid a dividend of $0.191 per share. This represents a $2.29 annualized dividend and a yield of 2.87%. The ex-dividend date of this dividend was Wednesday, May 1st.

TRADEMARK VIOLATION NOTICE: “Weik Capital Management Acquires 302 Shares of VANGUARD SCOTTS/VANGUARD SHORT-TERM (VCSH)” was first posted by Ticker Report and is owned by of Ticker Report. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international copyright laws. The original version of this article can be viewed at https://www.tickerreport.com/banking-finance/4354304/weik-capital-management-acquires-302-shares-of-vanguard-scotts-vanguard-short-term-vcsh.html.

Recommended Story: When is a capital gain realized?

Want to see what other hedge funds are holding VCSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for VANGUARD SCOTTS/VANGUARD SHORT-TERM (BMV:VCSH).

Institutional Ownership by Quarter for VANGUARD SCOTTS/VANGUARD SHORT-TERM (BMV:VCSH)

Receive News & Ratings for VANGUARD SCOTTS/VANGUARD SHORT-TERM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VANGUARD SCOTTS/VANGUARD SHORT-TERM and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Barry Zwarenstein Sells 7,663 Shares of Five9 Inc  Stock
Barry Zwarenstein Sells 7,663 Shares of Five9 Inc Stock
Venture Fund Vii L.P. Arch Sells 63,000 Shares of Syros Pharmaceuticals Inc  Stock
Venture Fund Vii L.P. Arch Sells 63,000 Shares of Syros Pharmaceuticals Inc Stock
Insider Selling: Neogen Co.  Director Sells 5,000 Shares of Stock
Insider Selling: Neogen Co. Director Sells 5,000 Shares of Stock
Neogen Co.  Director Sells $314,650.00 in Stock
Neogen Co. Director Sells $314,650.00 in Stock
Insider Selling: Airgain Inc  CEO Sells 22,464 Shares of Stock
Insider Selling: Airgain Inc CEO Sells 22,464 Shares of Stock
Insider Selling: Bottomline Technologies  Insider Sells 9,925 Shares of Stock
Insider Selling: Bottomline Technologies Insider Sells 9,925 Shares of Stock


© 2006-2019 Ticker Report